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Nuclear targeting of 
 
 
 
-catenin is an obligatory step in
Wnt signal transduction, but the factors that control im-
port and export remain to be clariﬁed. In this issue,
Hendriksen et al. (p. 785) show that the RanBP3 export
factor antagonizes 
 
 
 
-catenin/T cell factor (TCF) tran-
scription by targeting the signaling-competent form of
 
 
 
-catenin. We speculate that cells may use multiple ex-
port mechanisms to inhibit 
 
 
 
-catenin signaling in differ-
ent ways.
 
The Wnt/
 
 
 
-catenin signaling cascade is one of the core signal
transduction pathways driving tissue morphogenesis during
both development and tumor initiation and progression in hu-
man cancers. The multifunctional protein 
 
 
 
-catenin is a central
component in this pathway, transducing extracellular Wnt
signals by entering the nucleus and converting TCF-type
DNA-binding factors into activators of specific genes. How
the nuclear signaling form of 
 
 
 
-catenin is regulated by Wnts has
been a major focus in the field.
The most conspicuous consequence of Wnt signaling is
the inhibition of a constitutive degradation mechanism that
serves to keep the cytosolic pool of 
 
 
 
-catenin at low levels. In
the absence of Wnt, the NH
 
2
 
 terminus of 
 
 
 
-catenin is constitu-
tively phosphorylated by casein kinase 1
 
 
 
 at serine 45 and,
subsequently, by glycogen synthase kinase 3
 
 
 
 (GSK3
 
 
 
) at res-
idues 41, 37, and 33 (Yost et al., 1996; Liu et al., 2002). These
phosphorylation events are coordinated by the scaffold protein
Axin and by the adenomatous polyposis coli (APC) tumor sup-
pressor gene product (Ikeda et al., 1998). 
 
 
 
-catenin that is
phosphorylated at residues 37 and 33 is ultimately recognized
by the 
 
 
 
-TrCP E3 ligase, ubiquitylated, and rapidly degraded
(Hart et al., 1999). During Wnt activation, GSK3
 
 
 
 activity is
inhibited, allowing 
 
 
 
-catenin to escape degradation and to
accumulate in both cytoplasmic and nuclear compartments.
Elevated levels alone, however, fail to explain 
 
 
 
-catenin/TCF
transcriptional activation (Guger and Gumbiner, 2000), and it
is now understood that Wnt signaling is specifically mediated
through molecular forms of 
 
 
 
-catenin that remain unphosphor-
ylated at residues 37 and 41 (Staal et al., 2002).
How does phosphorylation of these residues modulate
 
 
 
-catenin  signaling? Although some evidence suggests that
phosphorylation can alter 
 
 
 
-catenin signaling activity at the
level of DNA binding (Sadot et al., 2002), other evidence
suggests that phosphorylation may affect nuclear localization
(Staal et al., 2002). By designing an antibody that specifically
recognizes 
 
 
 
-catenin dephosphorylated at residues 37 and 41,
Staal et al. (2002) discovered that this unphosphorylated form
specifically accumulated within the nuclei of cells activated by
Wnt. This important finding demonstrated that 
 
 
 
-catenin’s
nuclear localization is clearly regulated by an active, sig-
nal-dependent process. Whether this nuclear accumulation is
caused by enhanced import, reduced export, or selective reten-
tion, and which factors target this unphosphorylated form of
 
 
 
-catenin, have remained unknown.
In this issue, Hendriksen et al. (2005) set out to identify
these elusive regulators of 
 
 
 
-catenin import and export. Affinity
chromatography was used to uncover proteins from 
 
Xenopus
laevis 
 
extracts that interact with 
 
 
 
-catenin. Two phenylala-
nine-glycine repeat–containing proteins were identified as the
RanBP3  isoforms a and b. The Ran binding protein 3
(RanBP3) was originally identified as an exportin chromo-
some region maintenance 1 (CRM1)–dependent export factor,
where it binds directly to the nuclear exporting receptor
CRM1 and stimulates the export of CRM1 substrates that
contain a leucine-rich nuclear export signal (Englmeier et al.,
2001). Distinct from this mechanism, however, RanBP3’s ef-
fects on 
 
 
 
-catenin appear to be independent of CRM1. In this
regard, RanBP3 b, and to a lesser extent RanBP3 a, was shown
to bind directly to its 
 
 
 
-catenin substrate (rather than indirectly
through CRM1). Moreover, this interaction was enhanced by
Ran-GTP, whereas a mutant form of RanBP3 unable to bind
RanGTP exhibited reduced affinity for 
 
 
 
-catenin, consistent
with RanBP3 export function being coupled to a cycle of
RanGTP binding and hydrolysis (Fig. 1). Overexpression and
loss-of-function (small interfering RNA) approaches dem-
onstrate that RanBP3 is a negative regulator of 
 
 
 
-catenin
signaling in human cell lines and in 
 
X. laevis 
 
and 
 
Drosoph-
ila melanogaster 
 
embryos. Thus, the mechanism by which
RanBP3 inhibits 
 
 
 
-catenin signaling has remained highly con-
served throughout evolution.
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Distinct from negative regulators of Wnt signaling, like
APC and Axin, which control the posttranslational stability of
 
 
 
-catenin, RanBP3 antagonizes the nuclear accumulation of
 
 
 
-catenin. Importantly, the inhibitory function of RanBP3 does
not target all forms of 
 
 
 
-catenin, but instead targets the nu-
clear-signaling form. Specifically, depletion of RanBP3 in
Wnt-expressing cells leads to an increase of the NH
 
2
 
-terminally
unphosphorylated form of 
 
 
 
-catenin detected in a nuclear frac-
tion (using the antibody of Staal et al. [2002]). Conversely, an
antibody that is considered to recognize all forms of 
 
 
 
-catenin
shows no enhanced nuclear detection upon RanBP3 depletion,
indicating that there are forms of 
 
 
 
-catenin that are not regulated
by RanBP3. Although it was challenging to confirm this mecha-
nism using immunofluorescence methods in Wnt-expressing cell
lines because of low amounts of the signaling-active 
 
 
 
-catenin,
SW480 cells (which are mutant for APC and have very high
levels of cytoplasmic and nuclear 
 
 
 
-catenin) revealed specific
nuclear accumulation of the NH
 
2
 
-terminally  unphosphory-
lated 
 
 
 
-catenin. Remarkably, this nuclear signal was specifi-
cally diminished by RanBP3 overexpression, suggesting that
RanBP3 targets the transcriptionally active form of 
 
 
 
-catenin
for export into the cytoplasmic compartment.
How RanBP3 distinguishes between phosphorylated and
unphosphorylated forms of 
 
 
 
-catenin remains to be clarified.
Although Hendriksen et al. (2005) show that RanBP3 exhibits
better binding to full-length 
 
 
 
-catenin than the central arma-
dillo repeat region and other studies have shown that both NH
 
2
 
-
and COOH-terminal regions of 
 
 
 
-catenin can promote nuclear
export from 
 
X. laevis
 
 nuclei (Wiechens and Fagotto, 2001), fur-
ther studies are required to determine whether RanBP3 directly
recognizes the unphosphorylated NH
 
2
 
 terminus of 
 
 
 
-catenin.
Moreover, although this mechanism does not explain how the
unphosphorylated forms of 
 
 
 
-catenin become nuclear localized
in the first place, evidence that the nuclear export machinery
can recognize distinct molecular forms of 
 
 
 
-catenin opens up
the possibility that nuclear import factors may similarly distin-
guish between these forms. In this regard, a genome-wide RNA
interference screen in flies for activators and inhibitors of Wnt
signaling has uncovered factors that may collaborate with
RanBP3 to regulate the import and export of Wnt pathway
components (DasGupta et al., 2005).
Currently there are two models for nuclear export of
 
 
 
-catenin, one in which 
 
 
 
-catenin directly engages the nuclear
pore complex for export, and the other a CRM1-dependent
pathway that relies on nuclear export sequences provided by
another carrier, such as APC (for review see Henderson and
Fagotto, 2002). Because Hendriksen et al. (2005) demonstrate
that RanBP3 exports 
 
 
 
-catenin independent of APC and
CRM1, this suggests a third mechanism for nuclear export.
Why might the cell use so many different modes of 
 
 
 
-catenin
export? Perhaps different modes of export could allow for dif-
ferent degrees of signaling inhibition (Fig. 2). For example,
APC-mediated export may couple nuclear exit with degradation,
irreversibly inhibiting the pathway. This export mechanism may
predominate in the absence of Wnts or under conditions where a
pulse of Wnt signaling must be rapidly diminished. On the
other hand, RanBP3-dependent export may be less coordinated
with cytoplasmic degradation, and thus this mechanism may
predominate during times of more sustained Wnt activation.
How these different export mechanisms are calibrated to generate
Figure 1. RanBP3 promotes export of activated
 -catenin. During Wnt signaling, the Axin–GSK3 –APC
phosphorylation/predestruction complex is inacti-
vated and leads to cytosolic accumulation of a form
of  -catenin that is unphosphorylated at GSK3 -
dependent serines 37 and 41. This “activated” form is
then available to enter the nucleus and participate as
a coactivator for the transcription of TCF target genes.
Data presented by Hendriksen et al. (2005) supports
a model in which this activated form of  -catenin is
exported from the nucleus by RanBP3 in a RanGTP-
dependent manner. Cytosolic Ran GTPase-activating
proteins promote GTP hydrolysis and presumably
release the active form of  -catenin in the cytosol. 
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different levels and durations of Wnt signals is currently un-
clear, but Hendriksen et al. (2005) have provided us with new
insights into the regulation of 
 
 
 
-catenin nuclear export.
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Figure 2. Distinct modes of  -catenin nuclear export. APC-
directed export of  -catenin may be coupled to degradation,
whereas RanBP3-directed export may allow for cycles of
export and reimport. See text for details.